Table 2.
Study Visit 1 (Pre-Vitamin D3 Intervention) | Study Visit 2 (Post-Vitamin D3 Intervention) | |||||
25(OH)D | 1,25(OH)2D | PTH | 25(OH)D | 1,25(OH)2D | PTH | |
Fasting glucose (mg/dL) | −0.49† | −0.54* | 0.40 | 0.10 | −0.58* | 0.16 |
Fasting insulin (μIU/mL) | −0.08 | 0.03 | −0.27 | 0.14 | −0.37 | −0.00 |
HOMA-IR | −0.16 | −0.05 | −0.20 | 0.15 | −0.42 | 0.02 |
IL-6 (pg/mL) | 0.33 | 0.37 | −0.48 | −0.04 | −0.45 | −0.29 |
PAI-1 (ng/mL) | −0.31 | −0.33 | 0.66* | −0.29 | 0.38 | 0.59* |
Urinary TGF-β1/urine Creatinine (μg/dL) | −0.09 | 0.42 | 0.62* | −0.39 | −0.30 | 0.31 |
Adiponectin (μg/mL) | −0.31 | −0.53* | 0.34 | −0.05 | −0.68* | 0.15 |
Resistin (μg/L) | 0.22 | 0.52† | 0.16 | 0.23 | 0.40 | 0.33 |
Leptin (ng/mL) | 0.02 | −0.17 | 0.41 | 0.19 | −0.05 | 0.31 |
Table displays Pearson correlation coefficients (r) before and after vitamin D3 therapy (
P<0.10,
P<0.05).
25(OH)D=25-hydroxyvitamin D; 1,25(OH)2D = 1,25-dihydroxyvitamin D; PTH=parathyroid hormone; HOMA-IR=homeostatic model for insulin resistance; IL-6=interleukin 6; PAI-1=plasminogen activator inhibitor 1.